Concepedia

John B. Etienne

JB

9

Publications

489

Citations

9

H-Index

1995

Active since

Affiliations

Pfizer (United States)(Current)

John B. Etienne is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1995–2012

9

Publications

9

A method for the selective reduction of carbohydrate 4,6-O-benzylidene acetals

Michael P. DeNinno, John B. Etienne, Kimberly C. Duplantier · Tetrahedron Letters · 1995 · 220 citations

, , +7

3‘-Aminoadenosine-5‘-uronamides:  Discovery of the First Highly Selective Agonist at the Human Adenosine A <sub>3</sub> Receptor

Michael P. DeNinno, Hiroko Masamune, Lois K. Chenard et al. · Journal of Medicinal Chemistry · 2002 · 59 citations · Full text

The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents

Michael P. DeNinno, Melissa P. Andrews, Andrew Bell et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 45 citations · Full text

, , +8

Steroidal Glycoside Cholesterol Absorption Inhibitors

Michael P. DeNinno, Peter A. McCarthy, Kimberly C. Duplantier et al. · Journal of Medicinal Chemistry · 1997 · 36 citations

11-Ketotigogenin Cellobioside (Pamaqueside):  A Potent Cholesterol Absorption Inhibitor in the Hamster

Peter A. McCarthy, Michael P. DeNinno, Lee A. Morehouse et al. · Journal of Medicinal Chemistry · 1996 · 33 citations

, , +15

Rows per page

1–5 of 9